The company announced the closing of a five-year debt facility providing up to $150M in capital from Braidwell LP, a healthcare-focused investment firm. An initial $75M has been funded with the option to draw an additional $75M over the next year. The proceeds of the transaction will be used to repay the company’s outstanding debt and for other general corporate purposes.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IRTC:
- iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
- iRhythm announces results from CAMELOT study have been published
- Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm’s Zio Long-Term Continuous Monitoring Service
- iRhythm receives CE Marking under EU MDR for Zio monitor, ZEUS System
- iRhythm Tracker implies 12% upside to Q4 revenue consensus, says Wells Fargo
